rawfin.tv
AstraZeneca Shares Plunge on Bristol Myers Squibb Acquisition Talk
MarketsstocksAI Generated

AstraZeneca Shares Plunge on Bristol Myers Squibb Acquisition Talk

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

AstraZeneca shares fell sharply following reports the drugmaker is considering an acquisition of Bristol Myers Squibb. Analyst Fazeli expressed skepticism, stating the potential deal 'makes no sense' for AstraZeneca.

pharmaceuticalsM&Astock-decline

Related Articles

EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks
S&P 500 Early Reporters Show 83 Percent Surpass EPS Estimates

S&P 500 Early Reporters Show 83 Percent Surpass EPS Estimates

stocks